Empagliflozin on the risk of retinopathy in patients with type 2 diabetes: Results from the EMPRISE study

被引：0
|
作者：
Tesfaye, Helen [1 ]
Htoo, Phyo Than T. [2 ]
Paik, Julie M. [2 ]
Zakoul, Heidi [2 ]
Schmedt, Niklas [3 ]
Deruaz-Luyet, Anouk [3 ]
Koeneman, Lisette [4 ]
Wexler, Deborah [5 ]
Patorno, Elisabetta [2 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol, Dept Med, Boston, MA USA
[3] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[4] Lilly Deutschland GmbH, Bad Homburg, Germany
[5] Harvard Med Sch, Massachusetts Gen Hosp, Div Endocrinol, Dept Med,MGH Diabet Ctr, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
59
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [31] Risk indicators of diabetic retinopathy in patients with type 2 diabetes screened by fundus photographs: a study from Pakistan
    Shahid Ahsan
    Abdul Basit
    Kazi Rumana Ahmed
    Liaquat Ali
    Rabeya Khanam
    Asher Fawwad
    Muhammad Zafar Iqbal Hydrie
    International Journal of Diabetes in Developing Countries, 2015, 35 : 333 - 338
  • [32] Risk indicators of diabetic retinopathy in patients with type 2 diabetes screened by fundus photographs: a study from Pakistan
    Ahsan, Shahid
    Basit, Abdul
    Ahmed, Kazi Rumana
    Ali, Liaquat
    Khanam, Rabeya
    Fawwad, Asher
    Hydrie, Muhammad Zafar Iqbal
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2015, 35 : S333 - S338
  • [33] Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care A First Analysis From the EMPRISE Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Franklin, Jessica M.
    Najafzadeh, Mehdi
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly G.
    Sambevski, Steven
    Bessette, Lily G.
    Ortiz, Adrian J. Santiago
    Kulldorff, Martin
    Schneeweiss, Sebastian
    CIRCULATION, 2019, 139 (25) : 2822 - 2830
  • [34] Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care: A First Analysis From the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Franklin, Jessica
    Najafzadeh, Mehdi
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Bartels, Dorothee
    Gopalakrishnan, Chandrasekar
    Kulldorff, Martin
    Schneeweiss, Sebastian
    CIRCULATION, 2018, 138
  • [35] Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
    Seino, Yutaka
    Kim, Dae Jung
    Yabe, Daisuke
    Tan, Elise Chia-Hui
    Chung, Wook-Jin
    Ha, Kyoung Hwa
    Nangaku, Masaomi
    Node, Koichi
    Klement, Riho
    Yasui, Atsutaka
    Lei, Wei-Yu
    Lee, Sunwoo
    Kyaw, Moe H.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly G.
    Sheu, Wayne H-H
    ENDOCRINOLOGY DIABETES & METABOLISM, 2021, 4 (01)
  • [36] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes
    Kohler, Sven
    Salsali, Afshin
    Hantel, Stefan
    Kaspers, Stefan
    Woerle, Hans J.
    Kim, Gabriel
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2016, 38 (06) : 1299 - 1313
  • [37] Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
    Michael Müller
    Carl-Ludwig Schönfeld
    Tanja Grammer
    Vera Krane
    Christiane Drechsler
    Bernd Genser
    Thomas Kohnen
    Christoph Wanner
    Winfried März
    Scientific Reports, 10
  • [38] Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
    Mueller, Michael
    Schoenfeld, Carl-Ludwig
    Grammer, Tanja
    Krane, Vera
    Drechsler, Christiane
    Genser, Bernd
    Kohnen, Thomas
    Wanner, Christoph
    Maerz, Winfried
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] Safety and tolerability of empagliflozin in patients with Type 2 diabetes
    Salsali, A.
    Kohler, S.
    Hantel, S.
    Kim, G.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2016, 33 : 66 - 66
  • [40] COMPARATIVE EFFECTIVENESS AND SAFETY OF EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY
    Patorno, Elisabetta
    Pawar, Ajinkya
    Franklin, Jessica M.
    Najafzadeh, Mehdi
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly G.
    Bessette, Lily G.
    Kulldorff, Martin
    Schneeweiss, Sebastian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 683 - 683
12345